INDIANAPOLIS, Oct. 31, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) granted Premarket Approval (PMA) for its IgM antibody to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback